Sunflower Pharmaceutical Group Co.,Ltd (SHE: 002737)
China
· Delayed Price · Currency is CNY
20.90
-0.25 (-1.18%)
Sep 9, 2024, 1:47 PM CST
Sunflower Pharmaceutical Group Co.,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 967.32 | 1,119 | 867.22 | 704.74 | 584.45 | 565.42 | Upgrade
|
Depreciation & Amortization | 158.15 | 178.73 | 268.81 | 167.77 | 149.15 | 149.54 | Upgrade
|
Other Amortization | 6.05 | 4.52 | 1.77 | 2.17 | 1.64 | 1.32 | Upgrade
|
Loss (Gain) From Sale of Assets | -4.14 | -3.23 | -7.43 | -47.77 | 5.41 | -3.51 | Upgrade
|
Asset Writedown & Restructuring Costs | 0.48 | 0.48 | 26.43 | 29.68 | 38.34 | 1.72 | Upgrade
|
Loss (Gain) From Sale of Investments | -18.19 | -30.58 | 9.92 | -26.36 | -14.23 | -11.02 | Upgrade
|
Provision & Write-off of Bad Debts | -0.68 | -4.6 | 1.06 | 27.05 | -6.56 | 7.4 | Upgrade
|
Other Operating Activities | 42.42 | 54.88 | 39.18 | 52.53 | 44.18 | 107.56 | Upgrade
|
Change in Accounts Receivable | -434.79 | 77.04 | 26.33 | 38.45 | 332.38 | -57.22 | Upgrade
|
Change in Inventory | -52.23 | -241.47 | 73.5 | -152.67 | 101.66 | 130.82 | Upgrade
|
Change in Accounts Payable | -322.36 | -286.2 | 662.12 | 57.9 | -82.14 | 91.95 | Upgrade
|
Change in Other Net Operating Assets | 30.88 | 25.66 | 15.16 | 10.43 | - | - | Upgrade
|
Operating Cash Flow | 371.75 | 889.69 | 1,975 | 865.23 | 1,170 | 981.33 | Upgrade
|
Operating Cash Flow Growth | -80.00% | -54.96% | 128.30% | -26.04% | 19.21% | 13.29% | Upgrade
|
Capital Expenditures | -118.24 | -149.16 | -152.9 | -118.31 | -212.73 | -374.24 | Upgrade
|
Sale of Property, Plant & Equipment | 2.96 | 4.05 | 3.98 | 0.69 | 97.06 | 10.97 | Upgrade
|
Cash Acquisitions | - | - | - | -1.1 | - | - | Upgrade
|
Investment in Securities | 397.7 | 147.7 | -517.45 | -790.76 | -98.39 | 38.46 | Upgrade
|
Other Investing Activities | 35.64 | 33.61 | 21.94 | 19.76 | 10.21 | 11.12 | Upgrade
|
Investing Cash Flow | 318.06 | 36.2 | -644.43 | -889.72 | -203.85 | -313.69 | Upgrade
|
Short-Term Debt Issued | - | 4.43 | - | - | - | - | Upgrade
|
Long-Term Debt Issued | - | 10 | 420 | 306.58 | 350.52 | 450 | Upgrade
|
Total Debt Issued | 4.43 | 14.43 | 420 | 306.58 | 350.52 | 450 | Upgrade
|
Long-Term Debt Repaid | - | -426.47 | -238.12 | -383.49 | -466.38 | -220 | Upgrade
|
Total Debt Repaid | -49.88 | -426.47 | -238.12 | -383.49 | -466.38 | -220 | Upgrade
|
Net Debt Issued (Repaid) | -45.45 | -412.04 | 181.88 | -76.91 | -115.86 | 230 | Upgrade
|
Issuance of Common Stock | - | - | 22.13 | 28.01 | - | - | Upgrade
|
Repurchase of Common Stock | - | - | - | - | -83.57 | - | Upgrade
|
Common Dividends Paid | -878.77 | -588.51 | -416.7 | -212.19 | -594.01 | -601.28 | Upgrade
|
Other Financing Activities | -32.79 | -38.28 | -33.87 | -48.24 | 9.84 | -56.54 | Upgrade
|
Financing Cash Flow | -957 | -1,039 | -246.57 | -309.33 | -783.6 | -427.82 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.12 | 0.23 | -0.02 | - | - | 0.1 | Upgrade
|
Net Cash Flow | -267.31 | -112.71 | 1,084 | -333.82 | 182.42 | 239.92 | Upgrade
|
Free Cash Flow | 253.51 | 740.52 | 1,822 | 746.92 | 957.14 | 607.09 | Upgrade
|
Free Cash Flow Growth | -85.18% | -59.37% | 144.00% | -21.96% | 57.66% | 11.32% | Upgrade
|
Free Cash Flow Margin | 4.88% | 12.99% | 35.77% | 16.74% | 27.65% | 13.89% | Upgrade
|
Free Cash Flow Per Share | 0.43 | 1.27 | 3.11 | 1.28 | 1.64 | 1.04 | Upgrade
|
Cash Income Tax Paid | 606.85 | 723.41 | 579.81 | 565.31 | 436.69 | 493.54 | Upgrade
|
Levered Free Cash Flow | -98.23 | 373.85 | 1,537 | 698.11 | 530.97 | 317.91 | Upgrade
|
Unlevered Free Cash Flow | -96.8 | 377.58 | 1,543 | 704.48 | 535.59 | 325.5 | Upgrade
|
Change in Net Working Capital | 783.81 | 420.94 | -786.7 | -170.77 | -183.82 | -110.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.